Glutathione pathways in the brain

Biological Chemistry

Volumn 384, Issue 4, 2003, Pages 505-516

  Dringen, Ralf ^a,b   Hirrlinger, Johannes ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Astrocytes; Multidrug resistance proteins; Neurodegeneration; Neurons; Oxidative stress; Parkinson's disease

Indexed keywords

GLUTATHIONE; GLUTATHIONE DISULFIDE; MULTIDRUG RESISTANCE PROTEIN 1; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; AMINO ACID TRANSPORT; ASTROCYTE; BRAIN CELL; CELL FUNCTION; CELL TYPE; DEGENERATIVE DISEASE; DETOXIFICATION; HUMAN; HUNTINGTON CHOREA; IN VITRO STUDY; MACROGLIA; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

ANIMALS; ANTIOXIDANTS; ASTROCYTES; BRAIN CHEMISTRY; EXTRACELLULAR SPACE; GLUTATHIONE; HUMANS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

EID: 0038636003     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2003.059     Document Type: Review

References (154)

1. Akerboom, T.P., Bilzer, M., and Sies, H. (1982). The relationship of biliary glutathione disulfide efflux and intracellular glutathione disulfide content in perfused rat liver. J. Biol. Chem. 257, 4248-4252.
2. Akerboom, T., and Sies, H. (1990). Glutathione transport and its significance in oxidative stress. In: Glutathione: Metabolism and Physiological Functions, J. Vina, ed. (Boca Raton, FL, USA: CRC Press), pp. 45-55.
3. Anderson, M.E., Underwood, M., Bridges, R.J., and Meister, A. (1989). Glutathione metabolism at the blood-cerebrospinal fluid barrier. FASEB J. 3, 2527-2531.
4. Arthur, J.R. (2000). The glutathione peroxidases. Cell Mol. Life Sci. 57, 1825-1835.
5. Aw, T.Y., Ookhtens, M., and Kaplowitz, N. (1984). Inhibition of glutathione efflux from isolated rat hepatocytes by methionine. J. Biol. Chem. 259, 9355-9358.
6. Bains, J.S., and Shaw, C.A. (1997). Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res. Brain Res. Rev. 25, 335-358.
7. Ballatori, N., and Rebbeor, J.F. (1998). Roles of MRP2 and oatp1 in hepatocellular export of reduced glutathione. Semin. Liver Dis. 18, 377-387.
8. Ballerini, P., Di Iorio, P., Ciccarelli, R., Nargi, E., D'Alimonte, I., Traversa, U., Rathbone, M.P., and Caciagli, F (2002). Glial cells express multiple ATP binding cassette proteins which are involved in ATP release. Neuroreport 13, 1789-1792.
9. Bharath, S., Hsu, M., Kaur, D., Rajagopalan, S., and Andersen, J.K. (2002). Glutathione, iron and Parkinson's disease. Biochem. Pharmacol. 64, 1037-1048.
10. Bishai, I., and Coceani, F. (1992). Eicosanoid formation in the rat cerebral cortex. Contribution of neurons and glia. Mol. Chem. Neuropathol. 17, 219-238.
11. Bolanos, J.P., Heales, S.J., Peuchen, S., Barker, J.E., Land, J.M., and Clark, J.B. (1996). Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione. Free Radic. Biol. Med. 21, 995-1001.
12. Borst, P., and Oude Elferink, R. (2002). Mammalian ABC transporters in health and disease. Annu. Rev. Biochem. 71, 537-592.
13. Borst, P., Evers, R., Kool, M., and Wijnholds, J. (1999). The multidrug resistance protein family. Biochim. Biophys. Acta 1461, 347-357.
14. Borst, P., Evers, R., Kool, M., and Wijnholds, J. (2000). A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92, 1295-1302.
15. Brigelius-Flohé, R. (1999). Tissue-specific functions of individual glutathione peroxidases. Free Radic. Biol. Med. 27, 951-965.
16. Chatterjee, S., Noack, H., Possel, H., Keilhoff, G., and Wolf, G. (1999). Glutathione levels in primary glial cultures: monochlorobimane provides evidence of cell type-specific distribution. Glia 27, 152-161.
17. Clarke, D.D., and Sokoloff, L. (1999). Circulation and energy metabolism of the brain. In: Basic Neurochemistry: Molecular, Cellular, and Medical Aspects, G.J. Sigel, B.W. Agranoff, R.W. Albers, S.K. Fisher, and M.D. Uhler, eds. (Philadelphia, USA: Lippincott-Raven), pp. 637-669.
18. Clement, M.V., Long, L.H., Ramalingam, J., and Halliwell, B. (2002). The cytotoxicity of dopamine may be an artefact of cell culture. J. Neurochem. 81, 414-421.
19. Commandeur, J.N., Stijntjes, G.J., and Vermeulen, N.P. (1995). Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Role in bioactivation and detoxication mechanisms of xenobiotics, Pharmacol. Rev. 47, 271-330.
20. Cooper, A.J.L. (1997). Glutathione in the brain: disorders of glutathione metabolism. In: The Molecular and Genetic Basis of Neurological Disease, R.N. Rosenberg, S.B. Prusiner, S. Di Mauro, R.L. Barchi, and L.M. Kunk, eds. (Boston, USA: Butterworth-Heinemann), pp. 1195-1230.
21. Cooper, A.J., and Kristal, B.S. (1997). Multiple roles of glutathione in the central nervous system. Biol. Chem. 378, 793-802.
22. Cruz-Aguado, R., Francis-Turner, L., Díaz, C.M., and Antúnez, I. (2000a). Quinolinic acid lesion induces changes in rat striatal glutathione metabolism. Neurochem. Int. 37, 53-60.
23. Cruz-Aguado, R., Turner, L.F., Díaz, C.M., and Pinero, J. (2000b). Nerve growth factor and striatal glutathione metabolism in a rat model of Huntington's disease. Restor. Neurol. Neurosci. 17, 217-221.
24. Decleves, X., Regina, A., Laplanche, J.L., Roux, F., Boval, B., Launay, J.M., and Scherrmann, J.M. (2000). Functional expression of P-glycoprotein and multidrug resistance- associated protein (Mrp1) in primary cultures of rat astrocytes. J. Neurosci. Res. 60, 594-601.
25. DeCory, H.H., Piech-Dumas, K.M., Sheu, S.S., Federoff, H.J., and Anders, M.W. (2001). Efflux of glutathione conjugate of monochlorobimane from striatal and cortical neurons. Drug Metab. Dispos. 29, 1256-1262.
26. den Hartog, G.J., Haenen, G.R., Vegt, E., van der Vijgh, W.J., and Bast, A. (2002). Efficacy of HOCI scavenging by sulfur-containing compounds: antioxidant activity of glutathione disulfide? Biol. Chem. 383, 709-713.
27. Devesa, A., O'Connor, J.E., Garcia, C., Puertes, I.R., and Vina, J.R. (1993). Glutathione metabolism in primary astrocyte cultures: flow cytometric evidence of heterogeneous distribution of GSH content. Brain Res. 618, 181-189.
28. Dexter, D.T., Sian, J., Rose, S., Hindmarsh, J.G., Mann, V.M., Cooper, J.M., Wells, F.R., Daniel, S.E., Lees, A.J., Schapira, A.H., Jenner, P., and Marsden, C.D. (1994). Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann. Neurol. 35, 38-44.
29. Do, K.Q., Trabesinger, A.H., Kirsten-Kruger, M., Lauer, C.J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., and Cuenod, M. (2000). Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur. J. Neurosci. 12, 3721-3728.
30. Dringen, R. (2000). Metabolism and functions of glutathione in brain. Prog. Neurobiol. 62, 649-671.
31. Dringen, R., and Gutterer, J.M. (2002). Glutathione reductase from bovine brain. Methods Enzymol. 348, 281-288.
32. Dringen, R., and Hamprecht, B. (1997). Involvement of glutathione peroxidase and catalase in the disposal of exogenous hydrogen peroxide by cultured astroglial cells. Brain Res. 759, 67-75.
33. Dringen, R., and Hamprecht, B. (1998). Glutathione restoration as indicator for cellular metabolism of astroglial cells. Dev. Neurosci. 20, 401-407.
34. Dringen, R., Kranich, O., and Hamprecht, B. (1997). The γ-glutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture. Neurochem. Res. 22, 727-733.
35. Dringen, R., Kussmaul, L., and Hamprecht, B. (1998). Rapid clearance of tertiary butyl hydroperoxide by cultured astroglial cells via oxidation of glutathione. Glia 23, 139-145.
36. Dringen, R., Pfeiffer, B., and Hamprecht, B. (1999). Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J. Neurosci. 19, 562-569.
37. Dringen, R., Gutterer, J.M., and Hirrlinger, J. (2000). Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. 267, 4912-4916.
38. Dringen, R., Gutterer, J.M., Gros, C., and Hirrlinger, J. (2001). Aminopeptidase N mediates the utilization of the GSH precursor CysGly by cultured neurons. J. Neurosci. Res. 66, 1003-1008.
39. Evers, R., de Haas, M., Sparidans, R., Beijnen, J., Wielinga, P.R., Lankelma, J., and Borst, P. (2000). Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br. J. Cancer 83, 375-383.
40. Favilli, F., Marraccini, P., Iantomasi, T., and Vincenzini, M.T. (1997). Effect of orally administered glutathione on glutathione levels in some organs of rats: role of specific transporters. Br. J. Nutr. 78, 293-300.
41. Fernandez-Checa, J.C., Takikawa, H., Horie, T., Ookhtens, M., and Kaplowitz, N. (1992). Canalicular transport of reduced glutathione in normal and mutant Eisai hyperbilirubinemic rats. J. Biol. Chem. 267, 1667-1673.
42. Finkel, T., and Holbrook, N.J. (2000). Oxidants, oxidative stress and the biology of ageing. Nature 408, 239-247.
43. Gu, M., Owen, A.D., Toffa, S.E., Cooper, J.M., Dexter, D.T., Jenner, P., Marsden, C.D., and Schapira, A.H. (1998). Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. J. Neurol. Sci. 158, 24-29.
44. Guo, N., McIntosh, C., and Shaw, C. (1992). Glutathione: new candidate neuropeptide in the central nervous system. Neuroscience 51, 835-842.
45. Hahn, R., Wendel, A., and Flohé, L. (1978). The fate of extracellular glutathione in the rat. Biochim. Biophys. Acta 539, 324-337.
46. Han, J., Cheng, F.C., Yang, Z., and Dryhurst, G. (1999). Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease. J. Neurochem. 73, 1683-1695.
47. Hermann, A., Varga, V., Oja, S.S., Saransaari, P., and Janaky, R. (2002). Involvement of amino-acid side chains of membrane proteins in the binding of glutathione to pig cerebral cortical membranes. Neurochem. Res. 27, 389-394.
48. Hertz, L., Dringen, R., Schousboe, A., and Robinson, S.R. (1999). Astrocytes: glutamate producers for neurons. J. Neurosci. Res. 57, 417-428.
49. Hirrlinger, J., König, J., Keppler, D., Lindenau, J., Schulz, J.B., and Dringen, R. (2001). The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress. J. Neurochem. 76, 627-636.
50. Hirrlinger, J., König, J., and Dringen, R. (2002a). Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones. J. Neurochem. 82, 716-719.
51. Hirrlinger, J., Schulz, J.B., and Dringen, R. (2002b). Effects of dopamine on the glutathione metabolism of cultured astroglial cells: implications for Parkinson's disease. J. Neurochem. 82, 458-467.
52. Hirrlinger, J., Schulz, J.B., and Dringen, R. (2002c). Glutathione release from cultured brain cells: multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells. J. Neurosci. Res. 69, 318-326.
53. Honda, K., Komoda, Y., and Inoue, S. (1994). Oxidized glutathione regulates physiological sleep in unrestrained rats. Brain Res. 636, 253-258.
54. Hopper, E., Belinsky, M.G., Zeng, H., Tosolini, A., Testa, J.R., and Kruh, G.D. (2001). Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP sub-family. Cancer Lett. 162, 181-191.
55. Iantomasi, T., Favilli, F., and Vincenzini, M.T. (1999). Evidence of glutathione transporter in rat brain synaptosomal membrane vesicles. Neurochem. Int. 34, 509-516.
56. Inoue, S., Honda, K., and Komoda, Y. (1995). Sleep as neuronal detoxification and restitution. Behav. Brain Res. 69, 91-96.
57. Ishikawa, T., and Sies, H. (1989). Glutathione as an antioxidant: toxicological aspects. In: Glutathione: Chemical, Biochemical, and Medical Aspects, B. Dolphin, O. Avramovic, and R. Poulson, eds. (New York, USA: John Wiley), pp. 85-109.
58. Jain, A., Martensson, J., Stole, E., Auld, P.A., and Meister, A. (1991). Glutathione deficiency leads to mitochondrial damage in brain. Proc. Natl. Acad. Sci. USA 88, 1913-1917.
59. Janaky, R., Ogita, K., Pasqualotto, B.A., Bains, J.S., Oja, S.S., Yoneda, Y., and Shaw, C.A. (1999). Glutathione and signal transduction in the mammalian CNS. J. Neurochem. 73, 889-902.
60. Janaky, R., Shaw, C.A., Varga, V., Hermann, A., Dohovics, R., Saransaari, P., and Oja, S.S. (2000a). Specific glutathione binding sites in pig cerebral cortical synaptic membranes. Neuroscience 95, 617-624.
61. Janaky, R., Varga, V., Hermann, A., Saransaari, P., and Oja, S.S. (2000b). Mechanisms of L-cysteine neurotoxicity. Neurochem. Res. 25, 1397-1405.
62. Jenner, P., and Olanow, C.W. (1998). Understanding cell death in Parkinson's disease. Ann. Neurol. 44, S72-S84.
63. Juurlink, B.H., Schultke, E., and Hertz, L. (1996). Glutathione release and catabolism during energy substrate restriction in astrocytes. Brain Res. 710, 229-233.
64. Kannan, R., Kuhlenkamp, J.F., Jeandidier, E., Trinh, H., Ookhtens, M., and Kaplowitz, N. (1990). Evidence for carrier-mediated transport of glutathione across the blood-brain barrier in the rat. J. Clin. Invest 85, 2009-2013.
65. Kannan, R., Kuhlenkamp, J.F., Ookhtens, M., and Kaplowitz, N. (1992). Transport of glutathione at blood-brain barrier of the rat: inhibition by glutathione analogs and age-dependence. J. Pharmacol. Exp. Ther. 263, 964-970.
66. Kannan, R., Yi, J.R., Tang, D., Li, Y., Zlokovic, B.V., and Kaplowitz, N. (1996). Evidence for the existence of a sodium-dependent glutathione (GSH) transporter. Expression of bovine brain capillary mRNA and size fractions in Xenopus laevis oocytes and dissociation from γ-glutamyltranspeptidase and facilitative GSH transporters. J. Biol. Chem. 271, 9754-9758.
67. Kannan, R., Mittur, A., Bao, Y., Tsuruo, T., and Kaplowitz, N. (1999). GSH transport in immortalized mouse brain endothelial cells: evidence for apical localization of a sodium-dependent GSH transporter. J. Neurochem. 73, 390-399.
68. +-dependent GSH transport in HCEC. Brain Res. 852, 374-382.
69. Kaplowitz, N., Fernandez-Checa, J.C., Kannan, R., Garcia-Ruiz, C., Ookhtens, M., and Yi, J.R. (1996). GSH transporters: molecular characterization and role in GSH homeostasis. Biol. Chem. Hoppe-Seyler 377, 267-273.
70. Keelan, J., Allen, N.J., Antcliffe, D., Pal, S., and Duchen, M.R. (2001). Quantitative imaging of glutathione in hippocampal neurons and glia in culture using monochlorobimane. J. Neurosci. Res. 66, 873-884.
71. Kirchhoff, F., Dringen, R., and Giaume, C. (2001). Pathways of neuron-astrocyte interactions and their possible role in neuroprotection. Eur. Arch. Psychiatry Clin. Neurosci. 251, 159-169.
72. König, J., Nies, A.T., Cui, Y., Leier, I., and Keppler, D. (1999). Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim. Biophys. Acta 1461, 377-394.
73. Kranich, O., Hamprecht, B., and Dringen, R. (1996). Different preferences in the utilization of amino acids for glutathione synthesis in cultured neurons and astroglial cells derived from rat brain. Neurosci. Lett. 219, 211-214.
74. Kranich, O., Dringen, R., Sandberg, M., and Hamprecht, B. (1998). Utilization of cysteine and cysteine precursors for the synthesis of glutathione in astroglial cultures: preference for cystine. Glia 22, 11-18.
75. Kussmaul, L., Hamprecht, B., and Dringen, R. (1999). The detoxification of cumene hydroperoxide by the glutathione system of cultured astroglial cells hinges on hexose availability for the regeneration of NADPH. J. Neurochem. 73, 1246-1253.
76. Lada, M.W., and Kennedy, R.T. (1997). In vivo monitoring of glutathione and cysteine in rat caudate nucleus using microdialysis on-line with capillary zone electrophoresis-laser induced fluorescence detection. J. Neurosci. Methods 72, 153-159.
77. Lai, L., and Tan, T.M. (2002). Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. Biochem. J. 361, 497-503.
78. 35S]glutathione binding sites in mouse and human spinal cord. J. Neurochem. 63, 155-160.
79. 4 and structurally related conjugates. J. Biol. Chem. 269, 27807-27810.
80. Leier, I., Jedlitschky, G., Buchholz, U., Center, M., Cole, S.P., Deeley, R.G., and Keppler, D. (1996). ATP-dependent glutathione disulphide transport mediated by the MRP gene- encoded conjugate export pump. Biochem. J. 314, 433-437.
81. Leslie, E.M., Deeley, R.G., and Cole, S.P. (2001). Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 167, 3-23.
82. Li, H., and Dryhurst, G. (1997). Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxylic acid (DHBT-1): a putative nigral endotoxin of relevance to Parkinson's disease. J. Neurochem. 69, 1530-1541.
83. Li, H., and Dryhurst, G. (2001). Oxidative metabolites of 5-S-cysteinyldopamine inhibit the pyruvate dehydrogenase complex. J. Neural Transm. 108, 1363-1374.
84. 4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter. J. Biol. Chem. 273, 16184-16191.
85. Li, L., Meier, P.J., and Ballatori, N. (2000). Oatp2 mediates bidirectional organic solute transport: a role for intracellular glutathione. Mol. Pharmacol. 58, 335-340.
86. Li, X., Orwar, O., Revesjo, C., and Sandberg, M. (1996). γ-Glutamyl peptides and related amino acids in rat hippocampus in vitro: effect of depolarization and γ-glutamyl transpeptidase inhibition. Neurochem. Int. 29, 121-128.
87. Li, X., Wallin, C., Weber, S.G., and Sandberg, M. (1999). Net efflux of cysteine, glutathione and related metabolites from rat hippocampal slices during oxygen/glucose deprivation: dependence on γ-glutamyl transpeptidase. Brain Res. 815, 81-88.
88. Loe, D.W., Deeley, R.G., and Cole, S.P. (2000). Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). J. Pharmacol. Exp. Ther. 293, 530-538.
89. Matsuo, M., Hamasaki, Y., Fujiyama, F., and Miyazaki, S. (1995). Eicosanoids are produced by microglia, not by astrocytes, in rat glial cell cultures. Brain Res. 685, 201-204.
90. McIntyre, T.M., and Curthoys, N.P. (1979). Comparison of the hydrolytic and transfer activities of rat renal γ-glutamyltranspeptidase. J. Biol. Chem. 254, 6499-6504.
91. Meister, A. (1974). Glutathione synthesis. Enzymes 10, 671-697.
92. Meister, A. (1991). Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol. Ther. 51, 155-194.
93. Mizuno, Y., Matuda, S., Yoshino, H., Mori, H., Hattori, N., and Ikebe, S. (1994). An immunohistochemical study on α-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann. Neurol. 35, 204-210.
94. Moss, S.J., and Smart, T.G. (2001). Constructing inhibitory synapses. Nature Rev. Neurosci. 2, 240-250.
95. 1H-MRS. Neurology 57, 1422-1427.
96. Nedergaard, M., Takano, T., and Hansen, A.J. (2002). Beyond the role of glutamate as a neurotransmitter. Nature Rev. Neurosci. 3, 748-755.
97. O'Connor, E., Devesa, A., Garcia, C., Puertes, I.R., Pellin, A., and Vina, J.R. (1995). Biosynthesis and maintenance of GSH in primary astrocyte cultures: role of L-cystine and ascorbate. Brain Res. 680, 157-163.
98. Ogita, K., Enomoto, R., Nakahara, F., Ishitsubo, N., and Yoneda, Y. (1995). A possible role of glutathione as an endogenous agonist at the N-methyl-D-aspartate recognition domain in rat brain. J. Neurochem. 64, 1088-1096.
99. Oja, S.S., Janaky, R., Varga, V., and Saransaari, P. (2000). Modulation of glutamate receptor functions by glutathione. Neurochem. Int. 37, 299-306.
100. Orlowski, M., and Wilk, S. (1975). In vivo inhibition of γ-glutamylcysteine synthetase by L-methionine-RS-sulfoximine; influence on intermediates of the γ-glutamyl cycle. J. Neurochem. 25, 601-606.
101. Orwar, O., Li, X., Andine, P., Bergstrom, C.M., Hagberg, H., Folestad, S., and Sandberg, M. (1994). Increased intra- and extracellular concentrations of γ-glutamylglutamate and related dipeptides in the ischemic rat striatum: involvement of γ-glutamyl transpeptidase. J. Neurochem. 63, 1371-1376.
102. Paulusma, C.C., van Geer, M.A., Evers, R., Heijn, M., Ottenhoff, R., Borst, P., and Oude Elferink, R.P. (1999). Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem. J. 338, 393-401.
103. Pearce, R.K., Owen, A., Daniel, S., Jenner, P., and Marsden, C.D. (1997). Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J. Neural Transm. 104, 661-677.
104. Peuchen, S., Duchen, M.R., and Clark, J.B. (1996). Modulation of the glutathione redox state in adult astrocytes. Biochem. Soc. Trans. 24, 449S.
105. Peuchen, S., Bolanos, J.P., Heales, S.J., Almeida, A., Duchen, M.R., and Clark, J.B. (1997). Interrelationships between astrocyte function, oxidative stress and antioxidant status within the central nervous system. Prog. Neurobiol. 52, 261-281.
106. Philbert, M.A., Beiswanger, C.M., Manson, M.M., Green, J.A., Novak, R.F., Primiano, T., Reuhl, K.R., and Lowndes, H.E. (1995). Glutathione S-transferases and γ-glutamyl transpeptidase in the rat nervous systems: a basis for differential susceptibility to neurotoxicants. Neurotoxicology 16, 349-362.
107. Rabinovic, A.D., and Hastings, T.G. (1998). Role of endogenous glutathione in the oxidation of dopamine. J. Neurochem. 71, 2071-2078.
108. Rabinovic, A.D., Lewis, D.A., and Hastings, T.G. (2000). Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine. Neuroscience 101, 67-76.
109. Rebbeor, J.F., Connolly, G.C., and Ballatori, N. (2002). Inhibition of Mrp2- and Ycf1p-mediated transport by reducing agents: evidence for GSH transport on rat Mrp2. Biochim. Biophys. Acta 171-178.
110. Richman, P.G., and Meister, A. (1975). Regulation of γ-glutamylcysteine synthetase by nonallosteric feedback inhibition by glutathione. J. Biol. Chem. 250, 1422-1426.
111. Sagara, J.I., Miura, K., and Bannai, S. (1993). Maintenance of neuronal glutathione by glial cells. J. Neurochem. 61, 1672-1676.
112. Sagara, J., Makino, N., and Bannai, S. (1996). Glutathione efflux from cultured astrocytes. J. Neurochem. 66, 1876-1881.
113. Salinas, A.E., and Wong, M.G. (1999). Glutathione S-transferases - a review. Curr. Med. Chem. 6, 279-309.
114. Sandberg, M., Li, X., Folestad, S., Weber, S.G., and Orwar, O. (1994). Liquid chromatographic determination of acidic β-aspartyl and γ-glutamyl peptides in extracts of rat brain. Anal. Biochem. 217, 48-61.
115. Schapira, A.H., Cooper, J.M., Dexter, D., Clark, J.B., Jenner, P., and Marsden, C.D. (1990). Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54, 823-827.
116. Schirmer, R.H., Krauth-Siegel, R.L., and Schulz, G.E. (1989). Glutathione reductase. In: Glutathione: Chemical, Biochemical, and Medical Aspects - Part A, B. Dolphin, O. Avramovic, and R. Poulson, eds. (New York, USA: John Wiley), pp. 553-596.
117. Schulz, J.B., Lindenau, J., Seyfried, J., and Dichgans, J. (2000). Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267, 4904-4911.
118. Shaw, C.A., Pasqualotto, B.A., and Curry, K. (1996). Glutathione-induced sodium currents in neocortex. Neuroreport 7, 1149-1152.
119. Shen, X.M., Li, H., and Dryhurst, G. (2000). Oxidative metabolites of 5-S-cysteinyldopamine inhibit the α-ketoglutarate dehydrogenase complex: possible relevance to the pathogenesis of Parkinson's disease. J. Neural Transm. 107, 959-978.
120. Sian, J., Dexter, D.T., Lees, A.J., Daniel, S., Agid, Y., Javoy-Agid, F., Jenner, P., and Marsden, C.D. (1994). Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36, 348-355.
121. Sies, H., and Akerboom, T.P. (1984). Glutathione disulfide (GSSG) efflux from cells and tissues. Methods Enzymol. 105, 445-451.
122. Sies, H., Gerstenecker, C., Menzel, H., and Flohé, L. (1972). Oxidation in the NADP system and release of GSSG from hemoglobin-free perfused rat liver during peroxidatic oxidation of glutathione by hydroperoxides. FEBS Lett. 27, 171-175,
123. Sisodiya, S.M., Lin, W.R., Harding, B.N., Squier, M.V., and Thom, M. (2002). Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 125, 22-31.
124. Sofic, E., Lange, K.W., Jellinger, K., and Riederer, P. (1992). Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 142, 128-130.
125. Spencer, J.P., Jenner, P., and Halliwell, B. (1995). Superoxide-dependent depletion of reduced glutathione by L-DOPA and dopamine. Relevance to Parkinson's disease. Neuroreport 6, 1480-1484.
126. Spencer, J.P., Jenner, P., Daniel, S.E., Lees, A.J., Marsden, D.C., and Halliwell, B. (1998). Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species. J. Neurochem. 71, 2112-2122.
127. Spencer, J.P., Whiteman, M., Jenner, P., and Halliwell, B. (2002). 5-S-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons. J. Neurochem. 81, 122-129.
128. Spiegl-Kreinecker, S., Buchroithner, J., Elbling, L., Steiner, E., Wurm, G., Bodenteich, A., Fischer, J., Micksche, M., and Berger, W. (2002). Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes. J. Neurooncol. 57, 27-36.
129. Stewart, V.C., Stone, R., Gegg, M.E., Sharpe, M.A., Hurst, R.D., Clark, J.B., and Heales, S.J. (2002). Preservation of extracellular glutathione by an astrocyte derived factor with properties comparable to extracellular superoxide dismutase. J. Neurochem. 83, 984-991.
130. Stokes, A.H., Hastings, T.G., and Vrana, K.E. (1999). Cytotoxic and genotoxic potential of dopamine. J. Neurosci. Res. 55, 659-665.
131. Stone, R., Stewart, V.C., Hurst, R.D., Clark, J.B., and Heales, S.J. (1999). Astrocyte nitric oxide causes neuronal mitochondrial damage, but antioxidant release limits neuronal cell death. Ann. NY Acad. Sci. 893, 400-403.
132. Sucher, N.J., and Lipton, S.A. (1991). Redox modulatory site of the NMDA receptor-channel complex: regulation by oxidized glutathione. J. Neurosci. Res. 30, 582-591.
133. Tammur, J., Prades, C., Arnould, I., Rzhetsky, A., Hutchinson, A., Adachi, M., Schuetz, J.D., Swoboda, K.J., Ptacek, L.J., Rosier, M., Dean, M., and Allikmets, R. (2001). Two new genes from the human ATP-binding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12. Gene 273, 89-96.
134. Tate, S.S., and Meister, A. (1974). Interaction of γ-glutamyl transpeptidase with amino acids, dipeptides, and derivatives and analogs of glutathione. J. Biol. Chem. 249, 7593-7602.
135. 1H NMR spectroscopy. J. Neurosci. Res. 66, 891-898.
136. Toffa, S., Kunikowska, G.M., Zeng, B.Y., Jenner, P., and Marsden, C.D. (1997). Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration. J. Neural Transm. 104, 67-75.
137. Ursini, F., Maiorino, M., Brigelius-Flohé, R., Aumann, K.D., Roveri, A., Schomburg, D., and Flohé, L. (1995). Diversity of glutathione peroxidases. Methods Enzymol. 252, 38-53.
138. Varga, V., Janaky, R., Saransaari, P., and Oja, S.S. (1994). Endogenous γ-L-glutamyl and β-L-aspartyl peptides and excitatory aminoacidergic neurotransmission in the brain. Neuropeptides 27, 19-26.
139. Varga, V., Jenei, Z., Janaky, R., Saransaari, P., and Oja, S.S. (1997). Glutathione is an endogenous ligand of rat brain N-methyl-D-aspartate (NMDA) and 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors. Neurochem. Res. 22, 1165-1171.
140. Vesce, S., Bezzi, P., and Volterra, A. (2001). Synaptic transmission with the glia. News Physiol. Sci. 16, 178-184.
141. Vila, M., Jackson-Lewis, V., Guegan, C., Wu, D.C., Teismann, P., Choi, D.K., Tieu, K., and Przedborski, S. (2001). The role of glial cells in Parkinson's disease. Curr. Opin. Neurol. 14, 483-489.
142. Wang, X.F., and Cynader, M.S. (2000). Astrocytes provide cysteine to neurons by releasing glutathione. J. Neurochem. 74, 1434-1442.
143. Wijnholds, J., Evers, R., van Leusden, M.R., Mol, C.A., Zaman, G.J., Mayer, U., Beijnen, J.H., van, d., V, Krimpenfort, P., and Borst, P. (1997). Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nature Med. 3, 1275-1279.
144. Wijnholds, J., Mol, C.A., van Deemter, L., de Haas, M., Scheffer, G.L., Baas, F., Beijnen, J.H., Scheper, R.J., Hatse, S., De Clercq, E., Balzarini, J., and Borst, P. (2000). Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc. Natl. Acad. Sci. USA 97, 7476-7481.
145. Wilson, J.X. (1997). Antioxidant defense of the brain: a role for astrocytes. Can. J. Physiol. Pharmacol. 75, 1149-1163.
146. Yang, C.S., Chou, S.T., Lin, N.N., Liu, L., Tsai, P.J., Kuo, J.S., and Lai, J.S. (1994). Determination of extracellular glutathione in rat brain by microdialysis and high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B Biomed. Appl. 661, 231-235.
147. Yonezawa, M., Back, S.A., Gan, X., Rosenberg, P.A., and Volpe, J.J. (1996). Cystine deprivation induces oligodendroglial death: rescue by free radical scavengers and by a diffusible glial factor. J. Neurochem. 67, 566-573.
148. 15N]glutamate. J. Neurochem. 55, 137-145.
149. Zängerle, L., Cuenod, M., Winterhalter, K.H., and Do, K.Q. (1992). Screening of thiol compounds: depolarization-induced release of glutathione and cysteine from rat brain slices. J. Neurochem. 59, 181-189.
150. Zeevalk, G.D., Bernard, L.P., Albers, D.S., Mirochnitchenko, O., Nicklas, W.J., and Sonsalla, P.K. (1997). Energy stress-induced dopamine loss in glutathione peroxidase- overexpressing transgenic mice and in glutathione-depleted mesencephalic cultures. J. Neurochem. 68, 426-429.
151. Zeevalk, G.D., Bernard, L.P., Sinha, C., Ehrhart, J., and Nicklas, W.J. (1998). Excitotoxicity and oxidative stress during inhibition of energy metabolism. Dev. Neurosci. 20, 444-453.
152. Zelcer, N., Saeki, T., Reid, G., Beijnen, J.H., and Borst, P. (2001). Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). J. Biol. Chem. 276, 46400-46407.
153. Zhang, J., Kravtsov, V., Amarnath, V., Picklo, M.J., Graham, D.G., and Montine, T.J. (2000). Enhancement of dopaminergic neurotoxicity by the mercapturate of dopamine: relevance to Parkinson's disease. J. Neurochem. 74, 970-978.
154. Zlokovic, B.V., Mackic, J.B., McComb, J.G., Weiss, M.H., Kaplowitz, N., and Kannan, R. (1994). Evidence for transcapillary transport of reduced glutathione in vascular perfused guinea-pig brain. Biochem. Biophys. Res. Commun. 201, 402-408.